NORML

JUNE 10, 2020

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 249

Chronic Pain Therapy Patients Topical 249

Canna Care Docs

OCTOBER 10, 2024

What could the implications be for patients on their medical cannabis journey? Rescheduling would ease those research barriers, improving access to data and education around the plant and opening the door to fully explore the medical benefits cannabis could provide. In the wake of this announcement, you may have a few questions.

Patients 111

Patients DEA Research and Development Recreational 111

NORML

FEBRUARY 28, 2020

Patients purchased an estimated $112 million worth of medical cannabis-related products in 2019, according to newly released Maine tax data. million) came from sales by caregivers to patients. Only the state’s lobster industry and potato industry bring in more annual revenue.

Data 208

Data Patients Retail Programs 208

Americans for Safe Access

MARCH 24, 2020

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.

Cannabinoids 247

Cannabinoids Data Safety Patients 247

The Cannigma

MARCH 25, 2021

In nursing school, I wrote my dissertation on the role of the nurse when caring for patients using cannabis therapeutically, knowing that nurses are often the first healthcare professional to whom patients disclose their cannabis use. I remain in awe of these patients to this day.

Patients 145

Patients Clinical Trials Medicine Events 145

NORML

APRIL 27, 2020

The Coalition letter focuses on the need for small business access to the SBA relief funds as an avenue to protect the progress that has been made by minority entrepreneurs in the emerging legal cannabis marketplaces. These services are especially crucial for vulnerable medical marijuana patients. You can read the full letter below.

Business 286

Business Access Policy Programs 286

The Cannigma

APRIL 12, 2023

MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. Back to our study.

Sleep 133

Sleep Data Tincture Research and Development 133

Cannabis Law Report

JUNE 21, 2021

Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Advantages of Data, Macro, and Micro. RYAH Group Inc.

Data 105

Data Clinical Trials Research and Development Indica 105

NORML

JULY 2, 2019

Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs.

Retail 204

Retail Sleep History Medicine 204

Veriheal

APRIL 11, 2024

million patients in 2022, a sharp increase from the 3.1 This data aligns with Americans’ rising acceptance of cannabis. While there have been some drops in medical patient registration in states with adult-use (recreational) programs, pandemic-era programs also directly attributed to part of the increase in patient registration.

Patients 111

Patients Chronic Pain Marijuana Conditions 111

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. Anonymized data also helps scientists better understand the cannabis plant and what products and chemical profiles are most effective for treating different conditions and symptoms.

Data 100

Data Research and Development Patients Strains 100

Cannabis Law Report

DECEMBER 27, 2019

A Windsor, Ontario-based company Audacia Bioscience is especially focussed on three patented technologies that deliver consumer and patient insights to the industry to close the knowledge gaps in the supply chain. AI-Powered search platform maximizes access to publications.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Veriheal

DECEMBER 14, 2021

An Analysis of Nationwide EVALI Data. Additionally, this one policy change made the odds of vaping as the primary form of consumption 40% lower, demonstrating that patients were ready and willing to switch from vaping to smoking home-grown cannabis once they were able.

Data 98

Data Vaping Legalization Consumption 98

Cannabis Law Report

AUGUST 23, 2021

Medicinal Cannabis Access Data Dashboard. To improve transparency and data accessibility, the TGA publishes de-identified data on the number of unapproved medicinal cannabis products accessed through the Special Access Scheme (SAS). Medicinal cannabis Special Access Scheme category B data.

Data 105

Data Access Medicine Patients 105

Veriheal

MAY 26, 2022

Patients around the world are in need of natural, alternative medical solutions, and Realm of Caring (RoC) is on a mission to serve them. RoC also works to increase patients’ access to medical cannabis by helping U.S. To date, Veriheal’s global team has helped hundreds of thousands of patients gain access to medical cannabis.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

CannaMD

MARCH 4, 2020

Releaf is a free mobile app to help patients track, learn from, and improve their use of medical cannabis. The data that is collected in Releaf App is used for multiple research studies and helps physicians identify what products patients are finding most effective. Patients can learn more by visiting ReleafApp.com.

Patients 79

Patients Data Collective Treatment 79

Cannabis Chronicles

MAY 22, 2019

SPOKANE — Researchers at Washington State University are teaming up with the Puyallup Tribe of Indians in an effort to chart the tribe’s outcomes prescribing medicinal marijuana to patients. This partnership with WSU and Qwibil will help us research the safety and efficacy of cannabis as medicine for our patients’ use.”.

Medicine 140

Medicine Research and Development Data Collective 140

NORML

MAY 21, 2019

The administration of oral CBD reduces cue-induced cravings and anxiety in subjects with a history of heroin use, according to clinical data published in The American Journal of Psychiatry. ” In observational models , patients with legal access to cannabis typically reduce or eliminate their use of opioids.

Clinical Trials 191

Clinical Trials CBD History Data 191

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Project CBD

AUGUST 6, 2019

Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. Results highlight the need for expanded patient access to CBD products.”.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

The Cannigma

FEBRUARY 2, 2021

In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Illinois News Joint

OCTOBER 9, 2024

In the 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), the Department of Financial & Professional Regulation (IDFPR) states in its data summary, “Looking ahead to Fiscal Year 2025, IDFPR has already begun its efforts to further expand access to cannabis both to consumers and medical patients.

Dispensary 116

Dispensary Patients Access Legislation 116

Illinois News Joint

DECEMBER 7, 2024

No data exists on how many registered medical patients are actively growing cannabis in Illinois. Though many reasons factor into the number of patients who grow and why, two trendlines that are heading in opposite direction may suggest more medical cannabis patients in Illinois are opting to grow their own medicine.

Patients 59

Patients Medicine Programs Dispensary 59

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

JANUARY 6, 2022

This blog post will explain how psilocybin patenting and other factors could make Oregon’s psilocybin program prohibitively expensive for low-income patients, and how big pharma is maneuvering to monopolize psychedelic therapy. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products.

Access 52

Access Patients Research and Development Treatment 52

Project CBD

AUGUST 6, 2019

Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data. Results highlight the need for expanded patient access to CBD products.”.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Illinois News Joint

OCTOBER 10, 2024

The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. This growth has allowed for the creation of new jobs, increased access to cannabis for consumers, and shows the State’s commitment to social equity in its cannabis programs.”

Seed-To-Sale 111

Seed-To-Sale Data Dispensary Agriculture 111

Cannabis Law Report

JANUARY 23, 2020

Click on image to access THSuite website. Report: Cannabis Users’ Sensitive Data Exposed in Data Breach. Led by internet privacy researchers Noam Rotem and Ran Locar, vpnMentor’s research team discovered a data breach in THSuite, a point-of-sale system in the cannabis industry. THSuite Company Profile.

Data 59

Data Dispensary Patients Medicine 59

The Cannigma

FEBRUARY 14, 2021

Years later, when medical cannabis was legalized in Maryland , where he lives, Smith told The Cannigma how he suddenly had access to a whole world of weed he had never encountered with his old dealer. There are several options out there for journaling your cannabis use, whether it’s as a patient, budding connoisseur, or any other reason.

Wellness and Beauty 145

Wellness and Beauty Data Terpenes Patients 145

SpeedWeed

AUGUST 31, 2021

16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. The Missouri Department of Health and Senior Services (DHSS) issued 56,448 new patient licenses and 12,062 renewed patient licenses between Dec. Psychiatric disorders accounted for 11,914 patients.

Programs 72

Programs Patients Dispensary Cultivation 72

Cannabis Law Report

JULY 13, 2021

The deal with LYPHE Group means that thousands of patients will be the first in Europe to have access to pain relief delivered in a metered dose via Kanabo’s VapePod. Kanabo’s medical line aims to enable patients to move away from the harmful habit of smoking medical cannabis flowers.

Extraction 105

Extraction Vaping Medicine Patients 105

Cannabis Law Report

JULY 2, 2022

reported a data breach stemming from a misconfigured web application that caused personal information to be accessible on the company’s website. On June 17, 2022, Silverstreak filed an official notice of the breach and sent out data breach letters to all affected parties. Can a Company Be Liable for an Accidental Data Breach?

Data 52

Data Access Topical Cannabis 52

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111

THC CBD Data Cannabinoids 111

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Illinois News Joint

MAY 16, 2023

Metrc stated, “Seamless data tracking in Metrc helps operators optimize inventory control, accurately report sales data, and improve cultivation management. To qualify and receive a medical patient card at a discounted rate, visit here. Illinois uses BioTrack as its current track-and-trace vendor.

Seed-To-Sale 98

Seed-To-Sale Supply Chain Data Compliance 98

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. The newsroom specifically requested aggregate data — information that would not identify individual patients.

Data 52

Data Treatment Patients Chronic Pain 52

The Cannigma

FEBRUARY 11, 2021

One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. That was shocking.”.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125